PsyQ

•

Chaîne • 5 émissions

Médecine

Médecine

30/06/2025
Médecine

Médecine

22/06/2025
Médecine

Médecine

30/06/2025
Sciences

Sciences

Chaque semaine
Médecine

Médecine

22/06/2025

30/06/2025

Chapter 7: Treatments for Mood Disorders

This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit upathak.substack.com

30/06/2025

•

35 min
29/06/2025

Chapter 4: Psychosis, Schizophrenia, and the Neurotransmitter Networks

This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit upathak.substack.com

29/06/2025

•

35 min
30/06/2025

Chapter 8: Anxiety, Trauma, and Treatment

This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit upathak.substack.com

30/06/2025

•

31 min
30/06/2025

Chapter 11: Attention Deficit Hyperactivity Disorder and Its Treatment

This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit upathak.substack.com

30/06/2025

•

39 min
7 FÉVR.

The Psychic Tourniquet: Ultra-Low-Dose Buprenorphine for Acute Suicidality - PsyQ Episode 37

In this episode of PsyQ, we confront the "zone of danger" in acute suicidality—the critical lag period where standard antidepressants often fail to address immediate "psychache". Anchored by the seminal Yovell et al. (2016) randomized controlled trial, we explore the neurobiological overlap between physical and social pain , testing the hypothesis that ultra-low-dose buprenorphine (starting at 0.1 mg) can modulate the endogenous opioid system to treat separation distress directly. We dissect the study's groundbreaking findings—including a significant reduction in suicidal ideation distinct from depression improvement and robust efficacy in patients with Borderline Personality Disorder —while rigorously outlining the safety parameters, zero-withdrawal protocols, and the critical clinical distinction between treating specific depressive symptoms and soothing the primal agony of the PANIC/GRIEF system. This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit upathak.substack.com

7 févr.

•

17 min
29/06/2025

Chapter 5: Targeting Dopamine and Serotonin Receptors for Psychosis, Mood, and Beyond

This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit upathak.substack.com

29/06/2025

•

22 min
29/06/2025

Chapter 1: Chemical Neurotransmission

This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit upathak.substack.com

29/06/2025

•

26 min
30/06/2025

Chapter 10: Disorders of Sleep and Wakefulness and Their Treatment

This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit upathak.substack.com

30/06/2025

•

33 min
21/06/2025

Chapter 4 - Neurotransmitters

This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit upathak.substack.com

21/06/2025

•

31 min
29/06/2025

Chapter 2: Transporters, Receptors, and Enzymes

This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit upathak.substack.com

29/06/2025

•

24 min

This is a channel featuring multiple psychiatric knowledge podcasts for trainees and clinicians. Content is AI generated, please consult original literature for the most up to date and accurate information. This content is for educational purposes only and is in no way commercialized.